Goose Grass Allergy: The Tropical Lawn Weed That Tricks Allergy Tests

Goose grass and crabgrass are two different species that homeowners frequently confuse because both are low-growing warm-season annual weeds with a similar spreading habit. Goose grass (Eleusine indica) belongs to subfamily Chloridoideae, the same subfamily as Bermuda grass. Crabgrass (Digitaria sanguinalis) belongs to subfamily Panicoideae. This matters for allergy because the two species have different cross-reactivity profiles: goose grass aligns immunologically with Bermuda grass, while crabgrass aligns with Johnson grass and bahia grass. If you are being tested for grass allergy and live in the South where both weeds are common, your allergist should include testing for both Chloridoideae and Panicoideae representatives rather than relying solely on Pooideae (Timothy) panels to screen for grass sensitization.

Standard grass allergy panels are heavily weighted toward Pooideae ('sweet grass') species like Timothy, ryegrass, and Kentucky bluegrass. These grasses contain Group 5 allergens (Phl p 5), which are the dominant IgE targets used in component-resolved diagnostics. But Chloridoideae species like goose grass and Bermuda grass completely lack Group 5 allergens. A patient sensitized primarily to goose grass will test negative for Phl p 5 and may also have low Timothy-specific IgE, leading to a false-negative grass panel even with clear seasonal hay fever. If you live in a warm southern state and experience June through October symptoms that have not been explained by standard testing, ask your allergist specifically about Bermuda grass specific IgE and Cyn d 1 component testing to screen for Chloridoideae sensitization.

Goose grass and Bermuda grass are closely related immunologically because both belong to subfamily Chloridoideae and share Group 1 beta-expansin allergen homologs. Patients sensitized to goose grass are expected to have significant cross-reactivity with Bermuda grass and vice versa. In practice, because no WHO/IUIS-named allergens exist specifically for Eleusine indica and no FDA-standardized extract is available, Bermuda grass testing serves as the clinical proxy for goose grass evaluation. A positive Bermuda grass skin prick test or Bermuda-specific IgE in a patient with June through October hay fever in the South provides sufficient evidence to diagnose Chloridoideae grass pollen allergy and guide immunotherapy with a Bermuda grass-based extract.

Goose grass is most prevalent in warm-climate states across the southern tier of the United States. The heaviest concentrations are found in Florida, Georgia, South Carolina, North Carolina, Texas, Louisiana, Mississippi, Alabama, and Southern California. The grass also extends into Arkansas, Tennessee, Virginia, Arizona, and Hawaii. It requires a frost-free period of adequate length to complete its annual life cycle, which limits its northern distribution. Patients living in Gulf Coast states have the longest potential goose grass exposure, with pollen season sometimes extending from June through November in frost-free areas. Climate change is gradually expanding the geographic range of warm-season grasses like goose grass northward.

Goose grass pollen can trigger asthma exacerbations in sensitized patients who have pre-existing airway hyperresponsiveness. Grass pollen is a well-established asthma trigger, and the mechanism — IgE-mediated mast cell activation in bronchial mucosa producing bronchoconstriction and airway inflammation — is identical regardless of which grass species is the sensitizing allergen. Patients who develop severe worsening of asthma during summer months and live in the southern US should be evaluated for goose grass and other warm-season grass sensitizations as potential drivers. During thunderstorm events, grass pollen grains can rupture into sub-pollen particles small enough to penetrate deeply into lower airways, creating a risk for severe thunderstorm asthma even in patients with mild to moderate baseline disease. Optimizing asthma controller medications before the June through October season is strongly recommended for all grass-sensitized asthmatic patients.

Goose grass is a prolific pollen producer relative to its small size. As a warm-season annual that flowers continuously from summer into fall, goose grass plants release pollen daily throughout the season, with peak output occurring in warm, dry, windy morning hours. The plant's low-growing, prostrate habit means its pollen heads are close to ground level and can be significantly disrupted by mowing, foot traffic, or wind, creating local exposure events that exceed ambient pollen counts. In densely infested lawns, disturbing goose grass-covered areas during mowing or yard work can produce locally elevated exposures comparable to walking through a field of flowering grass. Wearing a face mask during lawn maintenance and mowing before goose grass has started flowering in early summer are practical strategies for reducing high-exposure events.

Timothy grass immunotherapy, including the FDA-approved Grastek SLIT tablet, is designed for Pooideae grass sensitization and relies on the Group 5 allergen (Phl p 5) cross-reactivity that is shared across virtually all Pooideae species. Because goose grass is a Chloridoideae species and completely lacks Group 5 allergens, Timothy-based immunotherapy provides only partial coverage via shared Group 1 beta-expansin homologs. For patients with predominant Chloridoideae sensitization, Timothy immunotherapy alone is insufficient. Bermuda grass extract, which is FDA-standardized as an injectable (g2) and available in compounded sublingual formulations, is the appropriate immunotherapy choice for goose grass allergy. Component testing for Phl p 5 and Cyn d 1 helps determine whether a Timothy-alone or Bermuda-plus-Timothy approach is best for a given patient.

Goose grass pollen season peaks in July and August across most of the southern United States, coinciding with the hottest and driest weather of the year, which is optimal for pollen dispersal. By contrast, cool-season Pooideae grasses like Timothy and ryegrass peak in May and June before the heat sets in. This timing difference is clinically important: if your worst hay fever occurs in July and August rather than May and June, and you live in the South, you are more likely responding to warm-season sour grasses like goose grass or Bermuda than to Timothy or bluegrass. Pollen counts typically ease in September and October as nights cool, but in frost-free areas like South Florida and coastal Southern California, goose grass can pollinate into November. Ragweed peaks in the same August through October window, so differential diagnosis between ragweed and warm-season grass is important for late-summer symptoms.

The symptomatic treatment of goose grass allergy — nasal steroids, antihistamines, eye drops — is identical to that for any grass pollen allergy. The critical difference is in immunotherapy extract selection. Standard grass allergy immunotherapy uses Timothy grass as the Pooideae representative because it covers ryegrass, bluegrass, fescue, orchard grass, and the other sweet grasses through ~95 percent cross-reactivity. For goose grass, which is Chloridoideae, Bermuda grass extract must be used as the representative instead of Timothy. Patients who have been placed on Timothy-only immunotherapy for what is actually a Chloridoideae sensitization may experience less-than-expected benefit, which should prompt re-evaluation of their testing profile and extract selection. In some patients with both Pooideae and Chloridoideae sensitization, a combination formulation including both Timothy and Bermuda extracts is appropriate.

Yes, children can develop goose grass allergy, particularly those growing up in warm southern states where the grass is ubiquitous in lawns, schoolyards, and parks. Grass pollen allergy in children typically emerges in early school age, often between ages 3 and 7, after sufficient years of pollen exposure to complete sensitization. Children with a family history of atopy, eczema, or asthma are at higher risk of developing goose grass sensitization. In children, grass pollen allergy can manifest as seasonal hay fever, worsening asthma, or itchy eyes that are often attributed to other causes. A board-certified allergist can perform skin prick testing in children using age-appropriate protocols to confirm grass sensitization and recommend appropriate treatment, including sublingual immunotherapy drops which are particularly well-suited for pediatric patients who cannot tolerate allergy shots.